The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
Open accessAbstract
BACKGROUND The 2016 World Health Assembly endorsed the elimination of hepatitis B virus (HBV) infection as a public health threat by 2030; existing therapies and prophylaxis measures make such elimination feasible, even in the absence of a virological cure. We aimed to estimate the national, regional, and global prevalence of HBV in the general population and among children aged 5 years and younger, as well as the rates of diagnosis, treatment, prophylaxis, and the future burden globally. METHODS In this modelling study, we used a Delphi process with data from literature reviews and interviews with country experts to quantify the prevalence, diagnosis, treatment, and prevention measures for HBV infection. The PRoGReSs Model, a dynamic Markov model, was used to estimate the country, regional, and global prevalence of HBV infection in 2022, and the effects of treatment and prevention on disease burden. The future incidence of morbidity and mortality in the absence of additional interventions was also estimated at the global level. FINDINGS We developed models for 170 countries which resulted in an estimated global prevalence of HBV infection in 2022 of 3·2% (95% uncertainty interval 2·7-4·0), corresponding to 257·5 million (216·6-316·4) individuals positive for HBsAg. Of these individuals, 36·0 million were diagnosed, and only 6·8 million of the estimated 83·3 million eligible for treatment were on treatment. The prevalence among children aged 5 years or younger was estimated to be 0·7% (0·6-1·0), corresponding to 5·6 million (4·5-7·8) children with HBV infection. Based on the most recent data, 85% of infants received three-dose HBV vaccination before 1 year of age, 46% had received a timely birth dose of vaccine, and 14% received hepatitis B immunoglobulin along with the full vaccination regimen. 3% of mothers with a high HBV viral load received antiviral treatment to reduce mother-to-child transmission. INTERPRETATION As 2030 approaches, the elimination targets remain out of reach for many countries under the current frameworks. Although prevention measures have had the most success, there is a need to increase these efforts and to increase diagnosis and treatment to work towards the elimination goals. FUNDING John C Martin Foundation, Gilead Sciences, and EndHep2030.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H. L. A., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 5,391
Self-citationSchweitzer, A., Horn, J., Mikolajczyk, R. T., Krause, G., & Ott, J. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61412-x · Cited by 2,742
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
de Martel, C., Georges, D., Bray, F., Ferlay, J., & Clifford, G. M. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30488-7 · Cited by 2,475
Ott, J. J., Stevens, G. A., Groeger, J., & Wiersma, S. T. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.116 · Cited by 1,843
Razavi-Shearer, D., Gamkrelidze, I., Nguyen, M. H., Chen, D.-S., Van Damme, P., Abbas, Z., Abdulla, M., Abou Rached, A., Adda, D., Aho, I., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30056-6 · Cited by 1,661
Self-citationApplication of a Technique for Research and Development Program Evaluation
Malcolm, D. G., Roseboom, J. H., Clark, C. E., & Fazar, W. (1959) · Operations Research · doi:10.1287/opre.7.5.646 · Cited by 930
Sheena, B. S., Hiebert, L., Han, H., Ippolito, H., Abbasi-Kangevari, M., Abbasi-Kangevari, Z., Abbastabar, H., Abdoli, A., Abubaker Ali, H., Adane, M. M., et al. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00124-8 · Cited by 805
Self-citation[The guidelines of prevention and treatment for chronic hepatitis B (2019 version)].
(2019) · PubMed Central · doi:10.3760/cma.j.issn.1007-3418.2019.12.007 · Cited by 477
Requirements for global elimination of hepatitis B: a modelling study
Nayagam, S., Thursz, M., Sicuri, E., Conteh, L., Wiktor, S., Low-Beer, D., & Hallett, T. B. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30204-3 · Cited by 373
Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide
Maucort‐Boulch, D., de Martel, C., Franceschi, S., & Plummer, M. (2018) · International Journal of Cancer · doi:10.1002/ijc.31280 · Cited by 358
Cited by
Targeted protein degradation: advances in drug discovery and clinical practice
Zhong, G., Chang, X., Xie, W., & Zhou, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02004-x · Cited by 326
Metadata
- Authors
- Razavi-Shearer, D., Gamkrelidze, I., Pan, C., Jia, J., Berg, T., Gray, R., Lim, Y.-S., Chen, C.-J., Ocama, P., Desalegn, H., Abbas, Z., Abdallah, A., Aghemo, A., Ahmadbekova, S., Ahn, S. H., Aho, I., Akarca, U., Al Masri, N., Alalwan, A., Alavian, S., Al-Busafi, S., Aleman, S., Alfaleh, F., Alghamdi, A., Al-Hamoudi, W., Aljumah, A., Al-Naamani, K., Al-Rifai, A., Alserkal, Y., Altraif, I., Amarsanaa, J., Anderson, M., Andersson, M., Armstrong, P., Asselah, T., Athanasakis, K., Baatarkhuu, O., Ben-Ari, Z., Bensalem, A., Bessone, F., Biondi, M., Bizri, A. R., Blach, S., Braga, W., Brandão-Mello, C., Brosgart, C., Brown, K., Brown, Jr., Bruggmann, P., Brunetto, M., Buti, M., Cabezas, J., Casanovas, T., Chae, C., Chan, H. L. Y., Cheinquer, H., Chen, P.-J., Cheng, K. J., Cheon, M.-E., Chien, C.-H., Choudhuri, G., Christensen, P. B., Chuang, W.-L., Chulanov, V., Cisneros, L., Coffin, C., Contreras, F., Coppola, N., Cornberg, M., Cowie, B., Cramp, M., Craxi, A., Crespo, J., Cui, F., Cunningham, C., Dalgard, O., De Knegt, R., De Ledinghen, V., Dore, G., Drazilova, S., Duberg, A.-S., Egeonu, S., Elbadri, M., El-Kassas, M., El-Sayed, M., Estes, C., Etzion, O., Farag, E., Ferradini, L., Ferreira, P., Flisiak, R., Forns, X., Frankova, S., Fung, J., Gane, E., Garcia, V., García-Samaniego, J., Gemilyan, M., Genov, J., Gheorghe, L., Gholam, P., Gish, R., Goleij, P., Gottfredsson, M., Grebely, J., Gschwantler, M., Guingane, N. A., Hajarizadeh, B., Hamid, S., Hamoudi, W., Harris, A., Hasan, I., Hatzakis, A., Hellard, M., Hercun, J., Hernandez, J., Hockicková, I., Hsu, Y.-C., Hu, C.-C., Husa, P., Janicko, M., Janjua, N., Jarcuska, P., Jaroszewicz, J., Jelev, D., Jeruma, A., Johannessen, A., Kåberg, M., Kaita, K., Kaliaskarova, K., Kao, J.-H., Kelly-Hanku, A., Khamis, F., Khan, A., Kheir, O., Khoudri, I., Kondili, L., Konysbekova, A., Kristian, P., Kwon, J., Lagging, M., Laleman, W., Lampertico, P., Lavanchy, D., Lázaro, P., Lazarus, J. V., Lee, A., Lee, M.-H., Liakina, V., Lukšić, B., Malekzadeh, R., Malu, A., Marinho, R., Mendes-Correa, M. C., Merat, S., Meshesha, B. R., Midgard, H., Mohamed, R., Mokhbat, J., Mooneyhan, E., Moreno, C., Mortgat, L., Müllhaupt, B., Musabaev, E., Muyldermans, G., Naveira, M., Negro, F., Nersesov, A., Nguyen, V. T. T., Ning, Q., Njouom, R., Ntagirabiri, R., Nurmatov, Z., Oguche, S., Omuemu, C., Ong, J., Opare-Sem, O., Örmeci, N., Orrego, M., Osiowy, C., Papatheodoridis, G., Peck-Radosavljevic, M., Pessoa, M., Pham, T., Phillips, R., Pimenov, N., Pincay-Rodríguez, L., Plaseska-Karanfilska, D., Pop, C., Poustchi, H., Prabdial-Sing, N., Qureshi, H., Ramji, A., Rautiainen, H., Razavi-Shearer, K., Remak, W., Ribeiro, S., Ridruejo, E., Ríos-Hincapié, C., Robalino, M., Roberts, L., Roberts, S., Rodríguez, M., Roulot, D., Rwegasha, J., Ryder, S., Sadirova, S., Saeed, U., Safadi, R., Sagalova, O., Said, S., Salupere, R., Sanai, F., Sanchez-Avila, J. F., Saraswat, V., Sargsyants, N., Sarrazin, C., Sarybayeva, G., Schréter, I., Seguin-Devaux, C., Seto, W.-K., Shah, S., Sharara, A., Sheikh, M., Shouval, D., Sievert, W., Simojoki, K., Simonova, M., Sinn, D. H., Sonderup, M., Sonneveld, M., Spearman, C. W., Sperl, J., Stauber, R., Stedman, C., Sypsa, V., Tacke, F., Tan, S.-S., Tanaka, J., Tergast, T., Terrault, N., Thompson, A., Thompson, P., Tolmane, I., Tomasiewicz, K., Tsang, T.-Y., Uzochukwu, B., Van Welzen, B., Vanwolleghem, T., Vince, A., Voeller, A., Waheed, Y., Waked, I., Wallace, J., Wang, C., Weis, N., Wong, G., Wong, V., Wu, J.-C., Yaghi, C., Yesmembetov, K., Yip, T., Yosry, A., Yu, M.-L., Yuen, M.-F., Yurdaydin, C., Zeuzem, S., Zuckerman, E., & Razavi, H.
- Venue
- The Lancet Gastroenterology & Hepatology
- Publisher
- Elsevier BV
- Published
- 2023-10
- Volume
- 8
- Issue
- 10
- Pages
- 879-907
- ISSN
- 2468-1156 (ISSN-L)
- 2468-1253
- OpenAlex
- W4385297223
- Cited by
- 441
- References
- 30
- FWCI
- 73.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. https://app.cochat.ai/papers/10.1016/s2468-1253(23)00197-8
- The paper
- Razavi-Shearer, D., Gamkrelidze, I., Pan, C., Jia, J., Berg, T., Gray, R., Lim, Y.-S., Chen, C.-J., Ocama, P., Desalegn, H., Abbas, Z., Abdallah, A., Aghemo, A., Ahmadbekova, S., Ahn, S. H., Aho, I., Akarca, U., Al Masri, N., Alalwan, A., . . . Razavi, H. (2023). Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(23)00197-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.